Emmaus Life Sciences, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Baker Tilly, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.105 USD | +5.00% | +5.00% | +4.90% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.90% | 6.71M | |
+24.51% | 44.96B | |
+0.37% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.52% | 26.08B | |
-21.13% | 19.03B | |
+6.70% | 12.75B | |
+28.76% | 12.06B | |
-3.49% | 11.75B |
- Stock Market
- Equities
- EMMA Stock
- News Emmaus Life Sciences, Inc.
- Emmaus Life Sciences, Inc. Auditor Raises 'Going Concern' Doubt